Greenwich LifeSciences

-$1.77 (-4.27%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can buy or sell GLSI and other stocks, options, and ETFs commission-free!

About GLSI

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

CEO
Snehal Patel
Employees
Headquarters
Stafford, Texas
Founded
2006

GLSI Key Statistics

Market Cap
512.35M
Price-Earnings Ratio
Dividend Yield
Average Volume
203.34K
High Today
$41.00
Low Today
$39.17
Open Price
$41.00
Volume
86.12K
52 Week High
$158.07
52 Week Low
$3.26

GLSI Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
per share
Actual
Expected Jul 29, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure